General Drug Use Surveillance (All Patient Surveillance) of ENSPRYNG Syringes for Subcutaneous Injection - Prevention of relapses of neuromyelitis optica spectrum disorder (including neuromyelitis optica) -
Latest Information Update: 08 Jan 2022
At a glance
- Drugs Satralizumab (Primary)
- Indications Neuromyelitis optica
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 27 Aug 2020 New trial record